ADIL
Price
$1.05
Change
-$0.00 (-0.00%)
Updated
Dec 20, 04:59 PM (EDT)
BPMUF
Price
$52.83
Change
+$1.57 (+3.06%)
Updated
Oct 11 closing price
Ad is loading...

ADIL vs BPMUF

Header iconADIL vs BPMUF Comparison
Open Charts ADIL vs BPMUFBanner chart's image
Adial Pharmaceuticals
Price$1.05
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
Basilea Pharmaceutica AG
Price$52.83
Change+$1.57 (+3.06%)
Volume$135
CapitalizationN/A
ADIL vs BPMUF Comparison Chart
Loading...
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADIL vs. BPMUF commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADIL is a Hold and BPMUF is a Buy.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ADIL: $1.07 vs. BPMUF: $52.83)
Brand notoriety: ADIL and BPMUF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADIL: 68% vs. BPMUF: 100%
Market capitalization -- ADIL: $6.85M vs. BPMUF: $561.52M
ADIL [@Biotechnology] is valued at $6.85M. BPMUF’s [@Biotechnology] market capitalization is $561.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADIL’s FA Score shows that 1 FA rating(s) are green whileBPMUF’s FA Score has 1 green FA rating(s).

  • ADIL’s FA Score: 1 green, 4 red.
  • BPMUF’s FA Score: 1 green, 4 red.
According to our system of comparison, BPMUF is a better buy in the long-term than ADIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADIL’s TA Score shows that 5 TA indicator(s) are bullish while BPMUF’s TA Score has 1 bullish TA indicator(s).

  • ADIL’s TA Score: 5 bullish, 5 bearish.
  • BPMUF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, BPMUF is a better buy in the short-term than ADIL.

Price Growth

ADIL (@Biotechnology) experienced а -1.83% price change this week, while BPMUF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ADIL is expected to report earnings on Nov 13, 2023.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMUF($562M) has a higher market cap than ADIL($6.85M). BPMUF YTD gains are higher at: 28.854 vs. ADIL (-42.473). BPMUF has higher annual earnings (EBITDA): -4.5M vs. ADIL (-8.13M). BPMUF has more cash in the bank: 63M vs. ADIL (5.2M). ADIL has less debt than BPMUF: ADIL (194K) vs BPMUF (112M). BPMUF has higher revenues than ADIL: BPMUF (149M) vs ADIL (0).
ADILBPMUFADIL / BPMUF
Capitalization6.85M562M1%
EBITDA-8.13M-4.5M180%
Gain YTD-42.47328.854-147%
P/E RatioN/A51.42-
Revenue0149M-
Total Cash5.2M63M8%
Total Debt194K112M0%
FUNDAMENTALS RATINGS
ADIL vs BPMUF: Fundamental Ratings
ADIL
BPMUF
OUTLOOK RATING
1..100
9450
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9991
PRICE GROWTH RATING
1..100
5847
P/E GROWTH RATING
1..100
5932
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADIL's Valuation (22) in the Pharmaceuticals Major industry is significantly better than the same rating for BPMUF (89) in the null industry. This means that ADIL’s stock grew significantly faster than BPMUF’s over the last 12 months.

ADIL's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as BPMUF (100) in the null industry. This means that ADIL’s stock grew similarly to BPMUF’s over the last 12 months.

BPMUF's SMR Rating (91) in the null industry is in the same range as ADIL (99) in the Pharmaceuticals Major industry. This means that BPMUF’s stock grew similarly to ADIL’s over the last 12 months.

BPMUF's Price Growth Rating (47) in the null industry is in the same range as ADIL (58) in the Pharmaceuticals Major industry. This means that BPMUF’s stock grew similarly to ADIL’s over the last 12 months.

BPMUF's P/E Growth Rating (32) in the null industry is in the same range as ADIL (59) in the Pharmaceuticals Major industry. This means that BPMUF’s stock grew similarly to ADIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADILBPMUF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
18%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
13%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 6 days ago
17%
View a ticker or compare two or three
Ad is loading...
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXAS59.403.29
+5.86%
Exact Sciences Corp
PGY8.950.24
+2.76%
Pagaya Technologies Ltd
MX3.870.10
+2.65%
Magnachip Semiconductor Corp
CAAP18.880.24
+1.29%
Corporacion America Airports SA
CNSP0.11N/A
-1.82%
CNS Pharmaceuticals Inc

ADIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADIL has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ADIL jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADIL
1D Price
Change %
ADIL100%
+1.90%
SYRE - ADIL
39%
Loosely correlated
+3.16%
VANI - ADIL
36%
Loosely correlated
N/A
VTVT - ADIL
31%
Poorly correlated
+3.03%
BPMUF - ADIL
28%
Poorly correlated
N/A
GDTC - ADIL
27%
Poorly correlated
+4.92%
More

BPMUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMUF has been loosely correlated with AAVXF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMUF jumps, then AAVXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMUF
1D Price
Change %
BPMUF100%
N/A
AAVXF - BPMUF
47%
Loosely correlated
N/A
ABCZF - BPMUF
38%
Loosely correlated
N/A
ALZN - BPMUF
36%
Loosely correlated
-11.20%
GTBP - BPMUF
29%
Poorly correlated
-9.11%
NCNA - BPMUF
28%
Poorly correlated
N/A
More